'Simply stunning' - trastuzumab in HER2-positive breast cancer

Sheila A. Doggrel

    Research output: Contribution to journal › Comment/debate

    Fingerprint

    Dive into the research topics of ''Simply stunning' - trastuzumab in HER2-positive breast cancer'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Nursing and Health Professions